It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cells employ global genome nucleotide excision repair (GGR) to eliminate a broad spectrum of DNA lesions, including those induced by UV light. The lesion-recognition factor XPC initiates repair of helix-destabilizing DNA lesions, but binds poorly to lesions such as CPDs that do not destabilize DNA. How difficult-to-repair lesions are detected in chromatin is unknown. Here, we identify the poly-(ADP-ribose) polymerases PARP1 and PARP2 as constitutive interactors of XPC. Their interaction results in the XPC-stimulated synthesis of poly-(ADP-ribose) (PAR) by PARP1 at UV lesions, which in turn enables the recruitment and activation of the PAR-regulated chromatin remodeler ALC1. PARP2, on the other hand, modulates the retention of ALC1 at DNA damage sites. Notably, ALC1 mediates chromatin expansion at UV-induced DNA lesions, leading to the timely clearing of CPD lesions. Thus, we reveal how chromatin containing difficult-to-repair DNA lesions is primed for repair, providing insight into mechanisms of chromatin plasticity during GGR.
Cells employ global genome nucleotide excision repair to repair a broad spectrum of genomic DNA lesions. Here, the authors reveal how chromatin is primed for repair, providing insight into mechanisms of chromatin plasticity during DNA repair.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Faculty of Medicine, LMU Munich, Biomedical Center (BMC), Physiological Chemistry, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); International Max Planck Research School (IMPRS) for Molecular Life Sciences, Planegg-Martinsried, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091)
2 Leiden University Medical Center (LUMC), Department of Human Genetics, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
3 Erasmus University Medical Center, Department of Molecular Genetics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
4 Leiden University Medical Center (LUMC), Department of Cell and Chemical Biology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978); Andalusian Center For Molecular Biology and Regenerative Medicine (CABIMER), University of Seville, Genome Proteomics Laboratory, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229); University of Seville, Department of Cell Biology, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229)
5 The Hebrew University of Jerusalem, Department of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, Jerusalem, Israel (GRID:grid.9619.7) (ISNI:0000 0004 1937 0538)
6 CHU-Q: Laval University Hospital Research Centre of Quebec (CHUL site), Laboratory for Skin Cancer Research, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390)
7 Institute for Basic Science, Center for Genomic Integrity, Ulsan, Republic of Korea (GRID:grid.410720.0) (ISNI:0000 0004 1784 4496)
8 Institute for Basic Science, Center for Genomic Integrity, Ulsan, Republic of Korea (GRID:grid.410720.0) (ISNI:0000 0004 1784 4496); Ulsan National Institute of Science and Technology, Department of Biological Sciences, School of Life Sciences, Ulsan, Republic of Korea (GRID:grid.42687.3f) (ISNI:0000 0004 0381 814X)
9 Leiden University Medical Center (LUMC), Department of Cell and Chemical Biology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
10 Faculty of Medicine, LMU Munich, Biomedical Center (BMC), Physiological Chemistry, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); International Max Planck Research School (IMPRS) for Molecular Life Sciences, Planegg-Martinsried, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091); Eisbach Bio GmbH, Planegg-Martinsried, Germany (GRID:grid.511157.6)